July 18, 2019
Flex Pharma Announces Rights Dividend
Read More
July 12, 2019
Flex Pharma Announces Approval of all Merger-Related Proposals at Special Meeting
Read More
June 17, 2019
Flex Pharma Announces Overwhelming Support to Date for the Proposed Merger with Salarius Pharmaceuticals but More Votes are Needed to Complete the Merger
Read More
June 10, 2019
Flex Pharma Announces that ISS and Glass Lewis Recommend Shareholders Vote “FOR” All Agenda Items relating to Flex’s Strategic Merger with Salarius Pharmaceuticals
Read More
May 1, 2019
Flex Pharma Reports First Quarter 2019 Financial Results
Read More
March 6, 2019
Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results
Read More
January 4, 2019
Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer
Read More
November 5, 2018
Flex Pharma Reports Third Quarter 2018 Financial Results
Read More
August 1, 2018
Flex Pharma Reports Second Quarter 2018 Financial Results
Read More
June 13, 2018
Flex Pharma Announces Corporate Update
Read More
May 2, 2018
Flex Pharma Reports First Quarter 2018 Financial Results
Read More
April 25, 2018
Flex Pharma to Report First Quarter 2018 Financial Results on May 2, 2018
Read More
March 26, 2018
Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in Multiple Sclerosis
Read More
March 7, 2018
Flex Pharma Reports Year End 2017 Financial Results
Read More
February 28, 2018
Flex Pharma to Report Fourth Quarter and Full Year 2017 Results on March 7, 2018
Read More
February 8, 2018
NEW STUDY SHOWS HOTSHOT® PROVIDES RELIEF FROM MUSCLE SORENESS FOR ATHLETES OF ALL TYPES
Read More
February 6, 2018
Flex Pharma Presenting at BIO CEO on February 13, 2018
Read More
November 28, 2017
Enrollment Completed in Flex Pharma’s Phase 2 Exploratory Spasticity Study in MS
Read More
November 6, 2017
Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in ALS
Read More
November 6, 2017
Flex Pharma Reports Third Quarter 2017 Financial Results
Read More
November 2, 2017
Flex Pharma to Report Third Quarter 2017 Results on November 6, 2017
Read More
October 31, 2017
Flex Pharma Names Dr. Roger Tung to Its Board of Directors
Read More
October 16, 2017
Flex Pharma Initiates CMT Phase 2 Trial with FLX-787 in US
Read More
September 6, 2017
Flex Pharma Presenting at Upcoming Investor Conferences in September 2017
Read More
August 2, 2017
Flex Pharma Reports Second Quarter 2017 Financial Results
Read More
August 1, 2017
Flex Pharma Initiates ALS Phase 2 Trial with FLX-787 in US
Read More
July 31, 2017
Flex Pharma Names William McVicar President and Chief Executive Officer
Read More
July 26, 2017
Flex Pharma to Report Second Quarter 2017 Results on August 2, 2017
Read More
July 25, 2017
FDA Grants Fast Track Designation to Flex Pharma’s FLX-787 for the Treatment of Severe Muscle Cramps Associated with ALS
Read More
June 5, 2017
Flex Pharma Announces Executive Leadership Transition
Read More
June 2, 2017
Flex Pharma’s Phase 2 Trial with FLX-787 in Charcot-Marie-Tooth Endorsed by the Inherited Neuropathies Consortium
Read More
May 30, 2017
Flex Pharma Presenting at Upcoming Investor Conferences in June 2017
Read More
May 3, 2017
Flex Pharma Reports First Quarter 2017 Financial Results
Read More
April 26, 2017
FDA Clears Flex Pharma's FLX-787 to Commence US Phase 2 Trial in ALS Under IND
Read More
April 19, 2017
Flex Pharma Presents Human Efficacy Data on FLX-787 at the American Academy of Neurology Annual Meeting
Read More
April 5, 2017
Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Read More
March 21, 2017
Flex Pharma Inc at the Oppenheimer & Co. Inc. 27th Annual Healthcare Conference
Read More
March 13, 2017
Flex Pharma Presents at 29th Annual Roth Conference
Read More
March 8, 2017
Flex Pharma Reports Year End 2016 Financial Results
Read More
March 1, 2017
Flex Pharma to Report Fourth Quarter and Full Year 2016 Results on March 8, 2017
Read More
February 14, 2017
Flex Pharma to Present at the 2017 BIO CEO & Investor Conference
Read More
January 24, 2017
Flex Pharma Focuses on Phase 2 Clinical Programs in Severe Neurological Diseases
Read More
November 21, 2016
Flex Pharma to Present at the Piper Jaffray 28th Annual Healthcare Conference
Read More
November 9, 2016
Flex Pharma to Present at Jefferies 2016 Healthcare Conference
Read More
November 3, 2016
Hot and spicy could be cure for painful muscle cramps
Read More
November 2, 2016
Flex Pharma Reports Third Quarter 2016 Financial Results
Read More
October 26, 2016
Flex Pharma to Report Third Quarter 2016 Results on November 2, 2016
Read More
October 13, 2016
Flex Pharma Provides FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update
Read More
September 13, 2016
Flex Pharma Initiates Phase 2 Efficacy Study in Amyotrophic Lateral Sclerosis
Read More
September 1, 2016
Flex Pharma Presenting at Upcoming Investor Conferences in September 2016
Read More
August 26, 2016
Flex Pharma Announces Scientific Advisory Board Appointment and Management Change
Read More
August 3, 2016
Flex Pharma Reports Second Quarter 2016 Financial Results
Read More
July 27, 2016
Flex Pharma to Report Second Quarter 2016 Results on August 3, 2016
Read More
July 26, 2016
Flex Pharma Completes Enrollment of Human Proof of Concept Efficacy Study in Nocturnal Leg Cramps
Read More
July 11, 2016
Wall Street Journal: A New Way to Prevent Muscle Cramps
Read More
July 11, 2016
Wall Street Journal - Can Muscle Cramps Be Avoided?
Read More
July 6, 2016
Flex Pharma to Present at the Cantor Fitzgerald Healthcare Conference
Read More
June 15, 2016
Flex Pharma Initiates Phase 2 Efficacy Study in Multiple Sclerosis
Read More
June 3, 2016
Flex Pharma Presenting at Upcoming Investor Conferences in June 2016
Read More
May 25, 2016
Flex Pharma Initiates Human Efficacy Study with Single Molecule Tablet in Nocturnal Leg Cramps
Read More
May 4, 2016
Flex Pharma Reports First Quarter 2016 Financial Results
Read More
April 27, 2016
Flex Pharma to Report First Quarter 2016 Results on May 4, 2016
Read More
April 19, 2016
Flex Pharma's Positive Human NLC Study Selected for Presentation at AAN Annual Meeting
Read More
April 6, 2016
Flex Pharma Collaborator Penn State Presents Positive Human Muscle Cramp Data
Read More
March 18, 2016
The 'Cult Marketing' Plan Behind One Boston Biotech's Pending Product Launch
Read More
March 14, 2016
Flex Pharma Positive Human NLC Study Selected for Late-Breaking Presentation at AAN Annual Meeting
Read More
March 8, 2016
Flex Pharma Reports Year End 2015 Financial Results
Read More
March 7, 2016
Michelle V. Stacy Joins Flex Pharma's Board of Directors
Read More
March 1, 2016
Flex Pharma to Report Full Year 2015 Results on March 8, 2016
Read More
February 2, 2016
Flex Pharma Announces Positive Human Efficacy in Nocturnal Leg Cramp Study
Read More
January 21, 2016
Panelists Select 19 Companies for the 2016 Small-Cap Biotech Watchlist
Read More
January 6, 2016
Enrollment Completed in Flex Pharma's Exploratory Human Nocturnal Leg Cramp Study
Read More
December 21, 2015
Flex Pharma Added to NASDAQ Biotechnology Index
Read More
December 10, 2015
Flex Pharma in Running Times
Read More
December 9, 2015
Flex Pharma Presents at the 26th International Symposium on ALS/MND
Read More
November 30, 2015
Flex Pharma in Runner's World Online
Read More
November 23, 2015
Flex Pharma Presenting at Two Upcoming Healthcare Investor Conferences in December 2015
Read More
November 19, 2015
Flex Pharma in Bicycling.com
Read More
November 12, 2015
Flex Pharma in Women's Running Online
Read More
November 11, 2015
Flex Pharma Presenting at Two Upcoming Healthcare Investor Conferences in November 2015
Read More
November 10, 2015
Flex Pharma Announces FLX-787 as Clinical Drug Candidate
Read More
November 5, 2015
Flex Pharma in Competitor Online
Read More
November 4, 2015
Flex Pharma Reports Third Quarter 2015 Financial Results
Read More
November 3, 2015
Flex Pharma to Host Investor Day
Read More
October 29, 2015
Flex Pharma in Outside Magazine
Read More
October 28, 2015
Flex Pharma to Report Third Quarter 2015 Results on November 4, 2015
Read More
October 20, 2015
Flex Pharma Demonstrates Single Agent Efficacy and Dose Response in Reducing Human Muscle Cramps
Read More
October 13, 2015
Flex Pharma Co-Founder and Harvard Medical School Professor Bruce Bean to Speak about Chemical Neuro Stimulation at Neuro Advance Boston
Read More
October 8, 2015
Flex Pharma Named Official Sponsor of 2015 IRONMAN World Championship Presented by GoPro
Read More
October 7, 2015
Flex Pharma Partners with Five Time World Champion Triathlete Craig "Crowie" Alexander
Read More
October 7, 2015
Nobel Prize Winning Neuroscientist and Endurance Athlete to Share Sports Science Breakthrough at IRONMAN Sports Medicine Conference
Read More
October 6, 2015
Flex Pharma Demonstrates Efficacy of Synthesized Single and Combination Agents in Reducing Human Muscle Cramps
Read More
September 30, 2015
Flex Pharma Scientific Advisory Board Co-Chairs Host Inaugural Summit on Muscle Cramps and Spasms with International Clinical and Scientific Experts
Read More
September 22, 2015
Flex Pharma to Present at the Ladenburg Thalmann Investment Conference
Read More
September 21, 2015
Flex Pharma Educates Athletes about Breakthrough Discovery
Read More
September 9, 2015
Flex Pharma Appoints Kathie Lindemann Chief Operating Officer
Read More
September 8, 2015
Rob Perez Joins Flex Pharma Board of Directors
Read More
September 2, 2015
Flex Pharma to Present at the Rodman & Renshaw Investment Conference
Read More
August 5, 2015
Flex Pharma Reports Second Quarter 2015 Financial Results
Read More
July 29, 2015
Flex Pharma to Report Second Quarter 2015 Results on August 5, 2015
Read More
July 28, 2015
Flex Pharma Announces Two Poster Presentations at Upcoming Scientific Meetings
Read More
July 7, 2015
Flex Pharma Announces Reduction of Muscle Cramping in Athletes
Read More
July 1, 2015
Flex Pharma to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
Read More
June 15, 2015
Alfred Sandrock, Jr., M.D., Ph.D., Chief Medical Officer of Biogen, Joins Flex Pharma’s Scientific Advisory Board
Read More
June 2, 2015
Flex Pharma Presenting at Two Upcoming Consumer Investor Conferences in June 2015
Read More
June 1, 2015
Flex Pharma to Ring the NASDAQ Stock Market Closing Bell
Read More
May 28, 2015
Flex Pharma Presenting at Two Upcoming Healthcare Investor Conferences in June 2015
Read More
May 6, 2015
Flex Pharma Reports First Quarter 2015 Financial Results
Read More
May 4, 2015
NSF Approves Flex Pharma’s Proprietary Formulation under NSF’s Certified for Sport® Program
Read More
April 27, 2015
Flex Pharma Initiates Human Proof-of-Concept Efficacy Study in Nocturnal Leg Cramps
Read More
April 21, 2015
Flex Pharma Data Presented at AAN Platform Session
Read More
April 13, 2015
John Winkelman, M.D., Ph.D., Joins Flex Pharma’s Scientific Advisory Board
Read More
April 6, 2015
Jeffrey D. Capello Appointed to Flex Pharma’s Board of Directors
Read More
April 1, 2015
Flex Pharma Added to Russell 3000®, Russell 2000®, and Russell Microcap® Indices
Read More
March 17, 2015
Flex Pharma Reports Year End 2014 Financial Results
Read More
March 16, 2015
Thomas Wessel, M.D., Ph.D., Appointed Chief Medical Officer
Read More
March 3, 2015
Medtronic, Leading Neurostimulation Company, Invests in Flex Pharma IPO
Read More
February 24, 2015
Nobel Laureate, Rod MacKinnon, M.D., Joins Flex Pharma’s Board of Directors
Read More
February 18, 2015
AAN Selects Flex Pharma Data for Oral Platform Presentation
Read More
February 11, 2015
Flex Pharma CEO Christoph Westphal, M.D., Ph.D., Joins BIO Emerging Companies Governing Board
Read More
February 4, 2015
Flex Pharma Announces Closing Of Initial Public Offering
Read More
January 28, 2015
Flex Pharma Announces Pricing Of Initial Public Offering
Read More
November 14, 2014
Flex Pharma Presents Results From Three Human Clinical Studies
Read More
October 27, 2014
Flex Pharma Appoints Marc Kozin and Stuart Randle to its Board of Directors
Read More
October 6, 2014
Flex Pharma Broadens Management Team
Read More
September 22, 2014
John Sculley, Former Pepsi-Cola Co President and Former Apple CEO, Joins Flex Pharma’s Board of Directors
Read More
September 8, 2014
Flex Pharma Raises $40 Million
Read More
August 11, 2014
Flex Pharma Announces Positive Results from Human Clinical Studies
Read More
July 21, 2014
Flex Pharma Forms Distinguished Scientific Advisory Board
Read More
May 1, 2014
Flex Pharma Cofounder Bruce Bean Elected to National Academy of Sciences
Read More
November 30, -0001
test
Read More
November 30, -0001
Flex Pharma Reports Second Quarter 2015 Financial Results
Read More
November 30, -0001
Read More
November 30, -0001
Read More